What is Theravance Biopharma, Inc. (TBPH)?
Theravance Biopharma, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of medicines primarily for the treatment of serious respiratory and other diseases. The company engages in the research and development of small molecule medicines and biologics, with an emphasis on addressing unmet medical needs. Its pipeline includes therapies targeting conditions such as chronic obstructive pulmonary disease, asthma, and other respiratory disorders. Theravance Biopharma operates through various stages of drug development, including preclinical research, clinical trials, and regulatory approval processes. The company collaborates with other pharmaceutical firms and research institutions to advance its product candidates. Headquartered in the United States, Theravance Biopharma emphasizes innovation in medicinal chemistry and drug delivery technologies. Its operations encompass both internal research efforts and external partnerships aimed at expanding its portfolio of therapeutic options. The company is part of the broader biotechnology and pharmaceutical industry, contributing to advancements in healthcare through its specialized focus on respiratory and other therapeutic areas.
Theravance Biopharma, Inc. Stock Price Today: Live Overview
The price today is shaped by current trading, with Theravance Biopharma, Inc. at $13.99. The intraday price has ranged from $13.52 to $13.98, showing a daily change percentage of +0.9461%.
FAQ: Theravance Biopharma, Inc. (TBPH)
What is the current price of TBPH stock?
Theravance Biopharma, Inc.'s last traded price is $13.99.
Does TBPH pay dividends?
Theravance Biopharma, Inc. does not pay dividends.
Does TBPH have a formal corporate presence or regional headquarters in the UAE?
Theravance Biopharma, Inc. operates in the UAE through partnerships without an official regional office or subsidiary.
What is TBPH best known for?
Theravance Biopharma, Inc. is most famous for its development of respiratory and other specialty medicines.
What assets are typically shown together with TBPH?
Commonly shown alongside TBPH: Novartis ADR, Grifols, Supernus Pharmaceuticals Inc
Latest shares articles



